SSKN
STRATA Skin Sciences, Inc.$0.000200 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $0.000200
Next earnings
Nov 11
in 15 days
1 year
−100.0%
from $1.68 · Oct 27
30 days
−96.0%
from $0.005000
52-week range
$0.00010000–1.93
−100% from high · low Aug 10
Avg volume 20D
99
Oct 26 spike 1.0K
Short interest
🔒 Subscribers only
New fund stakes
0
Q4 2025 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 mixed oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 11, 2026
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q4 2025: 1 added (0 new), 3 trimmed or exited.
- TrendDOWNTREND
94% below its 50-day average.
Who's buying
13F· Q4 20250
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | TRIM | $80.4K |
| VANGUARD GROUP INC | TRIM | $20.6K |
| UBS Group AG | DOUBLED | $1.3K |
| BANK OF AMERICA CORP /DE/ | TRIM | $155.00 |
| VANGUARD GROUP INC | TRIM | $48.5K |
| UBS Group AG | NEAR_EXIT | $762.00 |
| UBS Group AG | TRIM | $16.7K |
| JPMORGAN CHASE & CO | TRIM | $121.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
last action Feb 2025Recent actions
| Date | Firm | Rating |
|---|---|---|
| Feb 27, 2025 | Maxim Group INITIATE | Buy |
| May 16, 2023 | CG Capital REITERATE | Outperform |
| Nov 3, 2020 | HC Wainwright & Co. UPGRADE | Buy |
| Mar 17, 2020 | HC Wainwright & Co. DOWNGRADE | Neutral |
| Dec 9, 2019 | Ladenburg Thalmann INITIATE | Buy |
| Nov 21, 2019 | Oppenheimer INITIATE | Outperform |
Earnings setup
EstimatesNov 11
reports in 15 days
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Aug 19, 2026
Enforcement
STRATA SKIN SCIENCES, INC. v. LASEROPTEK AMERICA CORP. et al
Court ruling (paed) — Docket: 2:24-cv-04138
Aug 19, 2026
Enforcement
STRATA SKIN SCIENCES, INC. v. LASEROPTEK AMERICA CORP. et al
Court ruling (paed) — Docket: 2:24-cv-04138
Aug 11, 2026
Earnings date
SSKN Q2 2026 Earnings Scheduled — 2026-08-11
Jul 28, 2026
Press release
STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer
Medical device veteran poised to lead STRATA to market leadership and continued revenue growth as Company continues next development phase Medical…
May 18, 2026
Press release
New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA’s Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo
Multicenter prospective RCT published in JAAD confirms superiority of XTRAC® Excimer Laser plus oral JAK inhibitors over tacrolimus combination…
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 19, 2026 SEC
The court partially granted and partially denied Strata's motion to dismiss LaserOptek's counterclaims. The antitrust…
COURT-RULING — Impact 6/10
Aug 19, 2026 Event
STRATA SKIN SCIENCES, INC. v. LASEROPTEK AMERICA CORP. et al
Court ruling (paed) — Docket: 2:24-cv-04138
Aug 11, 2026 Earnings calendar
Mar 2, 2026 SEC SSKN Q2 2026 Earnings Scheduled — 2026-08-11
STRATA Skin Sciences, Inc. (SSKN) has filed Form 15-12G to terminate the registration of its Common Stock under…
15-12G — Impact 7/10
Dec 31, 2025 Inst.
RENAISSANCE TECHNOLOGIES LLC — TRIM
63,830 shares ($80.4K)
Dec 31, 2025 Inst.
VANGUARD GROUP INC — TRIM
16,375 shares ($20.6K)
SecBot reports
2 filings · 0 bullish · 1 bearish · 1 mixed- MIXED COURT-RULINGAug 19, 2026
The court partially granted and partially denied Strata's motion to dismiss LaserOptek's…
The dismissal of antitrust counterclaims removes a major overhang for SSKN, but the survival of defamation and false marking claims means discovery will proceed on Strata's public statements about…
- BEARISH 15-12GMar 2, 2026
STRATA Skin Sciences, Inc. (SSKN) has filed Form 15-12G to terminate the registration of its…
Traders should anticipate reduced liquidity and limited public information for SSKN going forward. Monitor OTC trading volume and any future press releases for material updates.
All SSKN filing & press-release reports (2)
- COURT-RULING reportAug 19, 2026
- 15-12G reportMar 2, 2026